Evommune EVMN
NYSE EVMN
$8.64 +0.80 (+10.14%)
As of: Nov 11, 2026 · 3:59 PM EST

Evommune (EVMN) Other financing activities (as filed) (2024 - 2025)

Updated

Evommune's Other financing activities (as filed) was -$350,000 in Q4 2025.

Analysis

Evommune (EVMN) Other financing activities (as filed) (2024 - 2025) Analysis & Trends

For FY2025, Other financing activities (as filed) at Evommune came in at -$1.22 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Evommune 285.17 Mn -352.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -350,000.00
Sep 30, 2025 -138,000.00
Jun 30, 2025 -678,000.00
Mar 31, 2025 -58,000.00
Dec 31, 2024 -215,000.00
API Access

Evommune Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EVMN&period=max&api_key=YOUR_API_KEY